Jin Medical International LtdZJYL
Price$1.94

Qualitative Analysis

Business overview

Business Overview

Jin Medical International Ltd. (NASDAQ: ZJYL) is a Cayman Islands holding company that operates primarily through its Chinese subsidiaries, including Changzhou Zhongjin Medical Co., Ltd.. Founded in 2006 and headquartered in Changzhou, Jiangsu Province, China, the company is a leading designer and manufacturer of wheelchairs and living aids products. Its core product portfolio focuses on manual and electric wheelchairs, wheelchair components, and other assistive devices designed for people with disabilities, the elderly, and individuals recovering from injuries. Additionally, the company has expanded its product offerings to include walking aids, oxygen concentrators, micro-hyperbaric oxygen chambers, and intelligent nano bathing equipment. Jin Medical serves both retail-style medical supply channels and larger buyers requiring customized products, distributing its products to over 40 distributors in China and more than 20 international distributors, with Japan and China representing its primary geographic markets.

Research as of 20 Jun 2026

Sources: 3

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
Chuzhou Manufacturing Facility ExpansionExpansion

Establishment of a new manufacturing facility in Chuzhou, Anhui, to scale up production of electric wheelchairs and senior mobility scooters.

Expected impact: Provides an annual capacity of 200,000 units of mid-to-high-end electric wheelchairs and senior mobility scooters, improving supply-chain resilience and cost control.

Sign in / Sign up to read more
InvestmentFunded in part by IPO proceeds and capital allocation strategies.
TimelineAchieved final construction milestones and regulatory clearance for Class I medical device production on December 29, 2025, with full-capacity production projected by the end of April 2026.
Product Portfolio Diversification and InnovationInnovation

Development and launch of innovative, lightweight, and ergonomic wheelchair models, electric mobility scooters, and living aids (such as portable nano-thermal therapy bath products and micro hyperbaric oxygen chambers).

Expected impact: Drives revenue growth and expands market reach beyond core manual wheelchairs into high-margin electric and therapeutic segments.

Sign in / Sign up to read more
InvestmentOngoing R&D allocation, including collaboration with academic institutions like Nanjing Tech University.
TimelineContinuous annual product rollouts.
Sources: 4

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Recent Acquisitions

Zhongjin Kangma Information Technology$105.3M

Acquisition of an 80% equity interest by the company's VIE to expand operations and market presence [1.4.2].

Financial impact: Financials are consolidated under U.S. GAAP.

Sign in / Sign up to read more

Strategic Partnerships

Nanjing Tech University (NJTech)R&D and Industrial Design Collaboration

Collaborative development of new-generation ultralight portable electric wheelchairs and electric mobility vehicles, combining NJTech's industrial design expertise with Jin Medical's electrical component manufacturing capabilities [1.4.3].

Terms: Not publicly disclosed

Sign in / Sign up to read more
Sources: 2
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.